Poland· PL-100254016
Doxazosin Aurobindo
A doxazosin product containing doxazosinum, registered in Poland by Aurobindo Pharma (Malta) Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Doxazosin is registered in 13 of 19 countries.
Countries holding a registration under ATC C02CA04 (doxazosin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Doxazosin · ATC C02CA04
13 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of doxazosin costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.35 in Italy to $0.59 in Switzerland — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Doxazosin · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.59
- IT Italy$0.35
The record
At a glance
URPL (Poland)- Active substance
- Doxazosinum
- Manufacturer
- Aurobindo Pharma (Malta) Limited
- Country
- Poland (PL)
- ATC code
- C02CA04
- ATC class
- Doxazosin
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 14
- gtin05909990901661
- gtin05909990901678
- gtin05909990901685
- gtin05909990901692
- gtin05909990901708
- gtin05909990901760
- gtin05909990901777
- gtin05909990901784
- gtin05909990901593
- gtin05909990901609
- gtin05909990901623
- gtin05909990901630
- gtin05909990901647
- gtin05909990901654
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
259 interactions on record for doxazosin.
Graded by severity as the source publishes them — 85 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxazosin · interactions on record
259 records
- 85 moderate
- 173 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxazosin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCarduraViatris Specialty LLC
- United KingdomCardura 1mg tabletsViatris UK Healthcare Ltd
- CanadaAPO-DOXAZOSINAPOTEX INC
- IrelandCARDURA 1mg TabletsViatris Healthcare Limited
- NetherlandsDoxazosine 1 PCH, tabletten 1 mgPharmachemie B.V.
- SwedenDoxazosin Mylan 1 mg TablettMylan AB
- ItalyBENURVIATRIS PHARMA S.R.L.
- SpainCARDURAN NEO 4 mg COMPRIMIDOS DE LIBERACION MODIFICADAViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Ascalan, Doxazosin 1a Pharma
- Bulgaria · Доксазосин Чайкафарма, Зоксон
- Cyprus · Cardura, Magurol
- Czechia · Doxazosin G.L. Pharma, Kamiren
- Germany · Cardular, Cardular Pp
- Denmark · Cardosin Retard, Carduran Retard
- Estonia · Cardura, Cardura Xl
- Spain · Carduran Neo, Doxazosina Alter
- France · Doxazosine L.P. Viatris, Doxazosine Lp Arrow
- United Kingdom (Northern Ireland) · Cardura, Cardura Xl
- Greece · Cardura, Maguran
- Croatia · Doxa, Doxazin
- Hungary · Cardura, Cardura Xl
- Ireland · Cardura, Cardura Xl
- Iceland · Cardosin Retard, Carduran Retard
- Italy · Benur, Cardura
- Lithuania · Cardura, Cardura Xl
- Latvia · Cardura, Cardura Xl
- Malta · Cardura, Doxatan
- Netherlands · Cardura Xl, Doxazosin Syri Pharma
- Norway · Carduran Cr
- Portugal · Cardura Gits, Doxazosina Generis
- Romania · Cardura Xl, Doxazosin Arena
- Sweden · Alfadil, Alfadil Bph
- Slovenia · Cardura Xl, Kamiren
- Slovakia · Kamiren Xl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2ab28386-6329-4056-95a0-dee9b94a2a14 GET /v1/drugs/2ab28386-6329-4056-95a0-dee9b94a2a14?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "1 mg",
"packaging": "05909990901593 ¦ Rp ¦ 69267\n10 tabl.\n05909990901609 ¦ Rp ¦ 69268\n14 tabl.\n05909990901623 ¦ Rp ¦ 69269\n15 tabl.\n05909990901630 ¦ Rp ¦ 69270\n20 tabl.\n05909990901647 ¦ Rp ¦ 69271\n28 tabl.\n05909990901654 ¦ Rp ¦ 69272\n30 tabl.\n05909990901661 ¦ Rp ¦ 69273\n50 tabl.\n05909990901678 ¦ Rp ¦ 69274\n56 tabl.\n05909990901685 ¦ Rp ¦ 69275\n60 tabl.\n05909990901692 ¦ Rp ¦ 69276\n90 tabl.\n05909990901708 ¦ Rp ¦ 69278\n98 tabl.\n05909990901760 ¦ Rp ¦ 69279\n100 tabl. w blistrze\n05909990901777 ¦ Rp ¦ 69280\n140 tabl.\n05909990901784 ¦ Rp ¦ 69281\n100 tabl. w pojemniku",
"substance": "Doxazosini mesilas 1.21 mg",
"common_name": "Doxazosinum",
"pl_product_id": "100254016",
"pozwolenie_nr": "18843",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about doxazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.